Published in Hepatitis Weekly, February 13th, 2006
Study 1: According to research from Germany, hairpin ribozymes (Rz) in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus (HCV) subgenomic replicons.
"Chronic HCV infection is a clinically important liver disease with limited therapeutic options in a significant proportion of patients. Therefore, novel efficient therapeutic agents are needed," wrote D. Jarczak and colleagues, Hannover Medical School
"Because the 5'- and 3'-untranslated regions...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.